CompoAtlas

FUNLYTE - RECHARGE

Food supplement declared in France, decision dated 12 November 2026

FUNLYTE - RECHARGE is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
VELYSIA LAB
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Sachet
Daily dose
1 stick par jour
Directions for use
Un stick par jour à diluer dans 500 ml d’eau.
Intended populations
General population, Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney failure, Infants (under 1 year), Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant, Autre : Equilibre électrolytique, Immunité
Flavourings
Lemon - Yuzu

Declaration 381490, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
taurine500 mg

Other active ingredients

NamePer day
dextrinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Sels de magnésium de l'acide citriqueMagnésium250 mg300 mg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Citrate de potassiumPotassiumpas de limite (données insuffisantes)80 mg
Chlorure de sodiumSodiumpas de limite (données insuffisantes)no fixed dose
Citrate de sodiumSodiumpas de limite (données insuffisantes)no fixed dose
Sélénite de sodiumSélénium255 µg50 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Citrate de zincZinc25 mg15 mg

Additives

E960, E330

Other ingredients

jus de citron

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line